Cell and Gene Therapy Market to Hit USD 190.82 Billion by 2033 | Growth at 22.7% CAGR

The global cell and gene therapy market is growing rapidly, projected to expand from USD 37.14 billion in 2025 to USD 190.82 billion by 2033, driven by rising R&D investment, increasing incidence of cancer and cardiovascular diseases, and a surge in clinical trials.

📥 Download Sample

The cell and gene therapy market is witnessing transformative growth as advanced therapeutics reshape how we treat rare and life-threatening diseases. Valued at USD 30.27 billion in 2024, the market is expected to soar at a CAGR of 22.7% from 2025 to 2033, reaching USD 190.82 billion. With breakthroughs like CAR-T therapies gaining FDA approval and the number of clinical trials accelerating worldwide, this sector is quickly becoming a cornerstone of modern healthcare innovation.

Growth Drivers

• Rising Pharmaceutical R&D: Global pharmaceutical research and development investments are projected to reach USD 232.5 billion by 2026, fueling more candidates in the cell and gene therapy pipeline.
• Increasing Cancer and Cardiovascular Cases: With cancer and cardiovascular diseases ranking among the top global causes of death, demand for targeted cell and gene therapies is growing.
• Expanding Clinical Trials: The number of active clinical trials rose by 25% between 2019 and 2020, with over 1,200 therapies currently in testing stages globally.

Market Challenges

Despite the potential, high operational expenses remain a hurdle. For instance, producing a single vial of 20 million cells can cost up to USD 30,000, and overall gene therapy manufacturing may range from USD 500,000 to 1 million.

Opportunities Ahead

The surge in clinical research and global collaborations is creating opportunities for pharmaceutical companies, academic institutes, and contract manufacturing organizations to expand their footprint in this space.

Regional Insights

• North America: Leading the market due to strong healthcare spending and institutional funding.
• Europe: Reported USD 2.6 billion in CGT funding in 2020, a 103% increase compared to prior years.
• Asia-Pacific & Rest of World: Emerging as growing markets with expanding biotech infrastructure.

Segment Highlights

• Therapy Type: Cell therapy dominates, with CAR-T leading in oncology treatments.
• Delivery Method: Ex vivo delivery is the largest segment due to its precision and effectiveness.
• End-User: Pharmaceutical and biotechnology companies are projected to post the highest growth.
• Application: Oncology remains the largest application area, with rising demand in dermatology and musculoskeletal treatments.

Key Players

• Thermo Fisher Scientific
• Merck KGaA
• Charles River Laboratories
• Lonza
• Catalent
• WuXi AppTec
• Takara Bio Inc.
• Nikon Corporation
• FUJIFILM Holdings Corporation
• Hoffmann-La Roche Ltd.
• Oxford Biomedica plc
• Amgen Inc.
• Novartis AG
• Pfizer Inc.
• Biogen Inc.

Recent Developments

• Charles River Laboratories acquired Cognate BioServices to expand CGT manufacturing capabilities (2021).
• Thermo Fisher Scientific purchased Henogen S.A. for USD 859.7 million in 2021 and acquired Brammer Bio for USD 1.7 billion in 2019, strengthening its position in viral vector manufacturing.

Conclusion

With a projected fivefold market growth by 2033, cell and gene therapy is set to revolutionize healthcare by providing personalized, effective, and potentially curative treatments. Companies that invest early in manufacturing capabilities and clinical trial pipelines are likely to lead this fast-evolving market.

About Us:

Straits Research is a leading global market intelligence and consulting firm, dedicated to delivering actionable insights and in-depth analysis across a wide range of industries. Our mission is to empower organizations, investors, and decision-makers with reliable data, strategic guidance, and forward-looking perspectives to help them thrive in a rapidly evolving business landscape.

Contact Us:

Email: sales@straitsresearch.com

Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)

Website: https://straitsresearch.com/